THE RISK OF OSTEONECROSIS OF THE JAW IN TAIWANESE OSTEOPOROTIC PATIENTS TREATED WITH ORAL ALENDRONATE OR RALOXIFENE

被引：0
|
作者：
Chiu, W. -Y. [1 ]
Chien, J. -Y. [2 ]
Yang, W. -S. [3 ]
Juang, J. -M J. [2 ]
Lee, J. -J. [4 ]
Tsai, K. -S. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan
来源：
OSTEOPOROSIS INTERNATIONAL | 2014年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P695
引用
收藏
页码：S430 / S431
页数：2
相关论文
共 50 条
  • [21] Osteonecrosis of the jaw in patients receiving oral bisphosphonates
    Athanassios Kyrgidis
    Konstantinos Vahtsevanos
    Osteoporosis International, 2010, 21 : 535 - 536
  • [22] Osteonecrosis of the jaw in patients receiving oral bisphosphonates
    Kyrgidis, Athanassios
    Vahtsevanos, Konstantinos
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (03) : 535 - 536
  • [23] Pathophysiology of Osteonecrosis of the Jaw in Patients Treated with Bisphosphonate
    Badel, Tomislav
    Pavicin, Ivana Savic
    Carek, Andreja Jelinic
    Rosin-Grget, Kata
    Grbesa, Durdica
    COLLEGIUM ANTROPOLOGICUM, 2013, 37 (02) : 645 - 651
  • [24] Osteonecrosis of the jaw in a patient treated with alendronate and then denosumab: A case of dramatic amelioration by minocycline and then etidronate
    Oizumi, Takefumi
    Imoto, Kazuhiro
    Bando, Kanan
    Tanaka, Yukinori
    Funayama, Hiromi
    Yamauchi, Kensuke
    Kumamoto, Hiroyuki
    Takahashi, Tetsu
    Endo, Yasuo
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2025, 37 (02) : 348 - 355
  • [25] Determination of the Risk of Osteonecrosis of the Jaw in Patients with Bone Metastasis Treated with Intravenous Bisphosphonates
    Unal, Dilek
    Oguz, Arzu
    Koc, Ali
    Goksu, Sema Sezgin
    Aksu, Yusuf
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2015, 5 (06) : 1183 - 1187
  • [26] Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer
    Van Poznak, Catherine
    Reynolds, Evan L.
    Estilo, Cherry L.
    Hu, Mimi
    Schneider, Bryan Paul
    Hertz, Daniel L.
    Gersch, Christina
    Thibert, Jacklyn
    Thomas, Dafydd
    Banerjee, Mousumi
    Rae, James M.
    Hayes, Daniel F.
    ORAL DISEASES, 2022, 28 (01) : 193 - 201
  • [27] Oral health management of patients at risk of medication-related osteonecrosis of the jaw
    不详
    British Dental Journal, 2017, 222 (12) : 930 - 930
  • [28] Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
    Kos, Marcin
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 319 - 324
  • [29] Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management
    Chan, Boon Hui
    Yee, Ruixiang
    Puvanendran, Rukshini
    Bin Ang, Seng
    SINGAPORE MEDICAL JOURNAL, 2018, 59 (02) : 70 - 75
  • [30] SIMULTANEOUS OCCURRENCE OF ATYPICAL FEMORAL FRACTURES AND OSTEONECROSIS OF THE JAW IN AN OSTEOPOROTIC WOMAN TAKING ALENDRONATE: REPORT OF A SECOND CASE
    Chiu, W. -Y.
    Lee, J. -J.
    Tsai, K. -S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S362 - S363
12345